CLINICAL TRIAL PHASE
READY FOR LAUNCH
If a manufacturer has received public funding, they are feeling the effects of the stock market downturn and may need to find ways to decrease budget and/or bring about additional funding sources.
If a manufacturer has received funding from private investors, there may be more inherent cash security, but they must still work to ensure that investors have confidence that the product can continue forward.
ABSORB & ADAPT
Do you need help determining the impact of COVID-19 on your launch and how to navigate forward? Click the button below to get in touch with our expert team.